SBT8230, AN ASGR1-DIRECTED TLR8 IMMUNOTAC THERAPEUTIC FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS, DEMONSTRATES FAVORABLE PRECLINICAL TOLERABILITY WITH LIVER-LOCALIZED ACTIVITY Graham Jang,Robert DuBose, Mike Comeau,Elsa Hay,Monica Childs, David Purdy,Jenny R. Chang,Jeff Adamo, Lisa Bogatzki,Jeannette Bannink,Brenda Stevens, Mollie Daugherty,Ray Carillo,Li-Qun Fan,Ben Setter,Hengyu Xu, Sateesh Natarajan,Phil Tan,Yvette Latchman,Sean Smith,Valerie Odegard,Peter BaumHEPATOLOGY（2021）引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
